NAD+ Supplements: What the Science Actually Shows

NAD+ boosters are among the best-selling supplements in the longevity aisle, and the pitch is seductive: a single molecule declines as you age, so top it back up and your cells run younger. The first half is well supported. Pills containing nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR) really do raise NAD+ levels in human blood. The second half is where the evidence thins out. Across the human trials run so far, results on the things people actually care about, such as strength, endurance and metabolism, have been modest and mixed, and no trial has shown that an NAD+ booster extends human lifespan or reverses aging. This is a story about a real biological signal, a thin clinical record, a tangled regulatory fight, and a marketing machine that runs ahead of both.

What NAD+ actually does

NAD+, short for nicotinamide adenine dinucleotide, is a coenzyme present in every living cell. It shuttles electrons during the reactions that turn food into energy, and it is consumed by enzymes that repair DNA, regulate inflammation and govern circadian rhythm, including the sirtuin proteins that longevity researchers have studied for years. NAD+ levels fall with age in many tissues, and that decline is one of the cleanest, most reproducible observations in aging biology.

That correlation is the engine behind the NAD+ supplement market. The logic runs: if NAD+ drops with age and is needed for repair and energy, then restoring it should help. It is a reasonable hypothesis. The catch is that a substance declining with age does not prove that replacing it reverses what age has done. Many things change with age, and correcting one marker does not automatically fix the rest. Demonstrating benefit means giving people the supplement and measuring whether they end up healthier, and that is where the field gets murky.

The evidence for NMN and NR in people

You cannot swallow NAD+ directly and expect much to reach your cells, so supplements use precursors the body converts into NAD+. The two most popular are NR and NMN, both relatives of vitamin B3. On the most basic question, do they raise NAD+, the answer is a fairly confident yes. Studies in healthy adults have shown that 1,000 mg of NR daily substantially elevates NAD+ in blood and muscle, and chronic NMN supplementation raises blood NAD+ levels in older adults.

Beyond that, the picture fragments. A 2023 review of NMN human trials reported scattered functional gains, such as longer six-minute walk distances and faster sit-to-stand times in some studies, while VO2 max and grip strength were frequently unchanged. Sleep results pointed both ways, and cardiovascular and metabolic readings such as LDL cholesterol and blood pressure improved in some studies and not in others.

The NR record is similar. A randomized trial in peripheral artery disease found NR improved walking distance, while trials in Parkinson’s disease have mostly confirmed that NR is safe and raises NAD+ without yet proving it changes the illness. The honest summary, echoed by a 2026 systematic review, is that clear evidence for anti-aging effects in humans remains scarce. Most trials are small, short and aimed at biomarkers rather than long-term outcomes. The supplements appear safe at studied doses, but safe is not the same as effective, a distinction these products often blur, much as the broader longevity supplement market does.

The regulatory fight over NMN

NMN’s legal status in the United States has lurched back and forth in a way that says a lot about how unsettled this field is. In late 2022 the FDA declared that NMN could no longer be sold as a dietary supplement, citing a clause that excludes any ingredient first studied as an investigational new drug. NMN had been the subject of a drug application from a company called MetroBiotech, which under the FDA’s reading disqualified it. NMN listings began disappearing from Amazon and other retailers.

The industry pushed back with a citizen petition and a lawsuit from the Natural Products Association. On September 29, 2025, the FDA reversed itself and confirmed NMN is lawful in supplements, concluding it had been marketed as a supplement as early as 2017, before the drug investigation began. The reversal restored access, but it turned on timing and statutory wording, not a verdict on whether NMN works. Consumers should not read the about-face as an endorsement of the health claims.

The marketing machine

If one figure embodies the gap between lab science and the sales pitch, it is Harvard geneticist David Sinclair, whose 2019 book promoted NAD+ precursors and sirtuins as central to aging. Fellow scientists have repeatedly argued he blurred the line between mouse studies and proven human outcomes. The criticism intensified over claims of age reversal in dogs and primates, and in March 2024 Sinclair stepped down as president of a longevity research academy after a wave of rebukes from peers, including aging researcher Matt Kaeberlein and biochemist Charles Brenner.

The commercial stakes run deep. The NR market grew up around ChromaDex, which sells the ingredient as Niagen, and Elysium Health, whose Basis product also used NR. The two ended up in a multi-year patent and contract battle, and a 2021 jury ordered Elysium to pay nearly $3 million for breaching a supply agreement. Brenner, who discovered NR, has said he prefers partners that fund safety research and avoid unproven claims, a reminder that not everyone selling these molecules is equally cautious. The same enthusiasm drives self-experimenters such as those following the Bryan Johnson Blueprint protocol, where NAD+ precursors feature prominently.

How a consumer should weigh the claims

Start by separating two questions: does the supplement raise NAD+, and does raising NAD+ make you healthier or younger. The first is reasonably settled; the second is not. If you try NMN or NR, treat it as a low-confidence bet on a generally well-tolerated compound, not a proven intervention, and keep expectations near the modest end of what trials have shown.

Be skeptical of before-and-after testimonials, “biological age” reductions tied to product sales, and any claim of reversing aging, which no human trial supports. Even epigenetic age tests carry their own uncertainties. None of this is medical advice; anyone with a health condition or on medication should talk to a clinician first. The most accurate thing to say in 2026 is that NAD+ boosters are a promising idea with real biochemical effects and an unfinished evidence base.

FAQ

Do NAD+ supplements actually raise NAD+ in the body? Yes. Multiple human trials show NR and NMN increase NAD+ in blood, and some show increases in muscle. That part of the science is consistent. What stays uncertain is whether higher NAD+ translates into meaningful health or anti-aging benefits.

Is NMN legal to buy in the United States? As of September 2025, yes. The FDA reversed its 2022 position and confirmed NMN is lawful in supplements because it was sold as one before being studied as a drug. That ruling concerns legal status, not proof that NMN works.

Will NAD+ supplements help me live longer? There is no human evidence that NAD+ boosters extend lifespan or reverse aging. Lifespan claims come from animal and laboratory work not replicated in people. Human trials so far report mixed, modest results.

Sources

1. PMC — The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: An Update
2. Science Advances — What is really known about the effects of nicotinamide riboside supplementation in humans
3. PMC — Chronic nicotinamide mononucleotide supplementation elevates blood NAD+ levels in healthy older men
4. Nature Communications — Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial
5. Nature Communications — NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease
6. ScienceDirect — NAD+ supplementation for anti-aging and wellness: a PRISMA-guided systematic review
7. Natural Products Association — FDA Reinstates NMN As Dietary Supplement After NPA Lawsuit
8. Venable LLP — FDA Declares Nicotinamide Mononucleotide Is a Dietary Supplement
9. Nutraceutical Business Review — FDA reverses stance to confirm NMN is lawful for use in dietary supplements
10. Nautilus — The Longevity Skeptic
11. NMN.com — David Sinclair resigns from top aging academy
12. C&EN — Firms feud over Niagen, a purported age-fighting molecule
13. NutraIngredients-USA — Split verdict in ChromaDex-Elysium jury case